pharma deals

Deal value drops by 34.2 per cent in April 2025, compared to April 2024

Read more

Shilpa Biologicals partners with mAbTree Biologics for novel immuno-oncology asset

Read more

Deal value declined by 86.4 per cent in Dec 2024, compared to Dec 2023

Read more

Funding in pharma surges in December 2024, reached $69.8 mn

Read more

Lupin acquires Huminsulin from Eli Lilly

Read more

Power Gummies raises ₹10 cr, aims to expand product range

Read more

M&A in pharma sees deals worth $14.8 bn in Nov 2024

Read more

Merck Life Science in India, GeNext Genomics sign MoU

Read more

Novo Holdings co-leads £90 million Series A financing for Myricx Bio

Read more

MASH innovator drug partnerships surge over $2.5 bn in 2024YTD: GlobalData

Read more